Sartorius Stedim Biotech (XPAR:DIM) EBIT per Share : €2.91 (TTM As of Sep. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Sartorius Stedim Biotech EBIT per Share?

Sartorius Stedim Biotech's EBIT per Share for the three months ended in Sep. 2024 was €0.75. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €2.91.

During the past 12 months, the average EBIT per Share Growth Rate of Sartorius Stedim Biotech was -53.80% per year. During the past 3 years, the average EBIT per Share Growth Rate was -2.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was 19.90% per year. During the past 10 years, the average EBIT per Share Growth Rate was 22.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Sartorius Stedim Biotech's EBIT per Share or its related term are showing as below:

XPAR:DIM' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -46.6 Med: 24.4 Max: 45.4
Current: -2.2

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Sartorius Stedim Biotech was 45.40% per year. The lowest was -46.60% per year. And the median was 24.40% per year.

XPAR:DIM's 3-Year EBIT Growth Rate is ranked worse than
59.52% of 714 companies
in the Medical Devices & Instruments industry
Industry Median: 6.95 vs XPAR:DIM: -2.20

Sartorius Stedim Biotech's EBIT for the three months ended in Sep. 2024 was €73 Mil.

Sartorius Stedim Biotech EBIT per Share Historical Data

The historical data trend for Sartorius Stedim Biotech's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech EBIT per Share Chart

Sartorius Stedim Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

3.49

5.07

7.13

12.47

5.62

Sartorius Stedim Biotech Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial															2.01	0.95	0.93	1.23	0.75

Sartorius Stedim Biotech EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Sartorius Stedim Biotech's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	518.1	/	92.161
=	5.62

Sartorius Stedim Biotech's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	73.4	/	98.077
=	0.75

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.91

Sartorius Stedim Biotech (XPAR:DIM) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Sartorius Stedim Biotech EBIT per Share Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius Stedim Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (XPAR:DIM) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

SRTOY:USA SDMHF:USA DIMp:UK 0RG8:UK 56S1:Germany DIM:Austria

Address

Otto-Brenner-Strasse 20, Goettingen, DEU, 37079

Website

https://www.sartorius.com

Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.